This statistic reveals Biogen's top products from 2022 to 2024, based on revenue. Biogen Inc. is a Massachusetts-based biotech company specializing in drugs for neurological disorders, autoimmune disorders and cancer. In 2024, one of the company's top products, Spinraza, generated revenues of around *** billion U.S. dollars.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
Biogen, & U.S. Securities and Exchange Commission. (February 14, 2025). Biogen's top products from 2022 to 2024, based on revenue (in million U.S. dollars) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 22, 2026, from /statistics/274271/biogen-idec-top-products-based-on-revenue/
Biogen, und U.S. Securities and Exchange Commission. "Biogen's top products from 2022 to 2024, based on revenue (in million U.S. dollars)." Chart. February 14, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 22, 2026. /statistics/274271/biogen-idec-top-products-based-on-revenue/
Biogen, U.S. Securities and Exchange Commission. (2025). Biogen's top products from 2022 to 2024, based on revenue (in million U.S. dollars). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 22, 2026. /statistics/274271/biogen-idec-top-products-based-on-revenue/
Biogen, and U.S. Securities and Exchange Commission. "Biogen's Top Products from 2022 to 2024, Based on Revenue (in Million U.S. Dollars)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 14 Feb 2025, /statistics/274271/biogen-idec-top-products-based-on-revenue/
Biogen & U.S. Securities and Exchange Commission, Biogen's top products from 2022 to 2024, based on revenue (in million U.S. dollars) ÌÇÐÄÆƽâ°æ, /statistics/274271/biogen-idec-top-products-based-on-revenue/ (last visited July 22, 2026)
Biogen's top products from 2022 to 2024, based on revenue (in million U.S. dollars) [Graph], Biogen, & U.S. Securities and Exchange Commission, February 14, 2025. [Online]. Available: /statistics/274271/biogen-idec-top-products-based-on-revenue/
